Shah Rajeev M. Insider Trading
Get the latest insider transactions of Shah Rajeev M.. Shah Rajeev M. is Director in KalVista Pharmaceuticals, Inc. ($CBYL) and in Kala Pharmaceuticals, Inc. ($KALA) and Director in Kala Pharmaceuticals, Inc. ($KALA) and Director in Ra Pharmaceuticals, Inc. ($RARX) and Director in Satsuma Pharmaceuticals, Inc. ($STSA) and Director in Black Diamond Therapeutics, Inc. ($BDTX) and Director in Solid Biosciences Inc. ($SLDB) and Director in Eidos Therapeutics, Inc. ($EIDX). Discover the current value of Shah Rajeev M. shares.
Address: C/O RA CAPITAL MANAGEMENT, LLC 20 PARK PLAZA, SUITE 1200 BOSTON 02116MA
Shah Rajeev M. is Insider in these Companies
| Ticker | Company Name | Current and Previous Positions | Total Shares | Current Value ($) |
|---|---|---|---|---|
| RARX | Ra Pharmaceuticals, Inc. | Director | 0 | 0.00 |
| KALV | KalVista Pharmaceuticals, Inc. | Director | 1,441,070 | 979,927.60 |
| KALA | Kala Pharmaceuticals, Inc. | 20,000 | ||
| SLDB | Solid Biosciences Inc. | Director | 8,709,882 | |
| EIDX | Eidos Therapeutics, Inc. | Director | 1,103,847 | |
| STSA | Satsuma Pharmaceuticals, Inc. | Director | 1,642,879 | |
| BDTX | Black Diamond Therapeutics, Inc. | Director | 0 |
Insider Trading Transactions of Shah Rajeev M.
| Date | Ticker | Company | Owner | Relationship | Transaction | Cost ($) | Shares | Transaction Value ($) | Total Shares |
|---|---|---|---|---|---|---|---|---|---|
| Jun 22 2021 | BDTX | Black Diamond Therapeutic ... | Shah Rajeev M. | Director | Option Exercise | 12.55 | 15,000 | 188,250 | 15,000 |
| Jun 21 2021 | KALA | Kala Pharmaceuticals, Inc ... | Shah Rajeev M. | Buy | 0.00 | 20,000 | 0 | 20,000 | |
| May 21 2021 | BDTX | Black Diamond Therapeutic ... | Shah Rajeev M. | Director | Sell | 24.01 | 443 | 10,636 | 0 |
| Apr 05 2021 | BDTX | Black Diamond Therapeutic ... | Shah Rajeev M. | Director | Buy | 24.26 | 353,814 | 8,583,528 | 2,277,978 |
| Mar 22 2021 | BDTX | Black Diamond Therapeutic ... | Shah Rajeev M. | Director | Buy | 24.01 | 443 | 10,636 | 443 |
| Dec 14 2020 | SLDB | Solid Biosciences Inc. | Shah Rajeev M. | Director | Buy | 3.70 | 4,938,282 | 18,271,643 | 8,709,882 |
| Dec 07 2020 | STSA | Satsuma Pharmaceuticals, ... | Shah Rajeev M. | Director | Option Exercise | 4.60 | 20,000 | 92,000 | 20,000 |
| Jun 29 2020 | KALA | Kala Pharmaceuticals, Inc ... | Shah Rajeev M. | Director | Buy | 0.00 | 20,000 | 0 | 20,000 |
| Jun 18 2020 | SLDB | Solid Biosciences Inc. | Shah Rajeev M. | Director | Option Exercise | 3.03 | 30,000 | 90,900 | 30,000 |
| Jun 16 2020 | STSA | Satsuma Pharmaceuticals, ... | Shah Rajeev M. | Director | Option Exercise | 26.99 | 10,000 | 269,900 | 10,000 |
| May 29 2020 | EIDX | Eidos Therapeutics, Inc. | Shah Rajeev M. | Director | Option Exercise | 48.51 | 21,528 | 1,044,323 | 21,528 |
| Apr 03 2020 | RARX | Ra Pharmaceuticals, Inc. | Shah Rajeev M. | Director | Sell | 48.00 | 4,858,260 | 233,196,480 | 0 |
| Apr 03 2020 | RARX | Ra Pharmaceuticals, Inc. | Shah Rajeev M. | Director | Option Exercise | 22.37 | 15,000 | 335,550 | 0 |
| Apr 03 2020 | RARX | Ra Pharmaceuticals, Inc. | Shah Rajeev M. | Director | Option Exercise | 9.90 | 15,000 | 148,500 | 0 |
| Apr 03 2020 | RARX | Ra Pharmaceuticals, Inc. | Shah Rajeev M. | Director | Option Exercise | 19.88 | 15,000 | 298,200 | 0 |
| Mar 13 2020 | KALA | Kala Pharmaceuticals, Inc ... | Shah Rajeev M. | Director | Buy | 7.89 | 6,337,135 | 49,999,995 | 10,874,613 |
| Feb 05 2020 | BDTX | Black Diamond Therapeutic ... | Shah Rajeev M. | Director | Buy | 0.00 | 956,723 | 0 | 956,723 |
| Feb 05 2020 | BDTX | Black Diamond Therapeutic ... | Shah Rajeev M. | Director | Buy | 0.00 | 163,353 | 0 | 163,353 |
| Feb 05 2020 | BDTX | Black Diamond Therapeutic ... | Shah Rajeev M. | Director | Buy | 0.00 | 186,749 | 0 | 186,749 |
| Feb 05 2020 | BDTX | Black Diamond Therapeutic ... | Shah Rajeev M. | Director | Buy | 0.00 | 181,783 | 0 | 1,138,506 |
| Feb 05 2020 | BDTX | Black Diamond Therapeutic ... | Shah Rajeev M. | Director | Buy | 0.00 | 70,770 | 0 | 234,123 |
| Feb 05 2020 | BDTX | Black Diamond Therapeutic ... | Shah Rajeev M. | Director | Buy | 0.00 | 30,526 | 0 | 217,275 |
| Feb 05 2020 | BDTX | Black Diamond Therapeutic ... | Shah Rajeev M. | Director | Buy | 19.00 | 785,658 | 14,927,502 | 1,924,164 |
| Feb 05 2020 | BDTX | Black Diamond Therapeutic ... | Shah Rajeev M. | Director | Buy | 19.00 | 77,803 | 1,478,257 | 311,926 |
| Feb 05 2020 | BDTX | Black Diamond Therapeutic ... | Shah Rajeev M. | Director | Buy | 19.00 | 136,539 | 2,594,241 | 353,814 |
| Feb 05 2020 | BDTX | Black Diamond Therapeutic ... | Shah Rajeev M. | Director | Option Exercise | 0.00 | 2,885,295 | 0 | 0 |
| Feb 05 2020 | BDTX | Black Diamond Therapeutic ... | Shah Rajeev M. | Director | Option Exercise | 0.00 | 492,643 | 0 | 0 |
| Feb 05 2020 | BDTX | Black Diamond Therapeutic ... | Shah Rajeev M. | Director | Option Exercise | 0.00 | 563,204 | 0 | 0 |
| Feb 05 2020 | BDTX | Black Diamond Therapeutic ... | Shah Rajeev M. | Director | Option Exercise | 0.00 | 548,224 | 0 | 0 |
| Feb 05 2020 | BDTX | Black Diamond Therapeutic ... | Shah Rajeev M. | Director | Option Exercise | 0.00 | 213,429 | 0 | 0 |
| Feb 05 2020 | BDTX | Black Diamond Therapeutic ... | Shah Rajeev M. | Director | Option Exercise | 0.00 | 92,063 | 0 | 0 |
| Sep 17 2019 | STSA | Satsuma Pharmaceuticals, ... | Shah Rajeev M. | Director | Buy | 0.00 | 1,642,879 | 0 | 1,642,879 |
| Sep 17 2019 | STSA | Satsuma Pharmaceuticals, ... | Shah Rajeev M. | Director | Buy | 0.00 | 1,139,635 | 0 | 2,782,514 |
| Sep 17 2019 | STSA | Satsuma Pharmaceuticals, ... | Shah Rajeev M. | Director | Buy | 0.00 | 365,530 | 0 | 3,148,044 |
| Sep 17 2019 | STSA | Satsuma Pharmaceuticals, ... | Shah Rajeev M. | Director | Buy | 0.00 | 200,481 | 0 | 3,348,525 |
| Sep 17 2019 | STSA | Satsuma Pharmaceuticals, ... | Shah Rajeev M. | Director | Buy | 15.00 | 1,140,946 | 17,114,190 | 4,489,471 |
| Sep 17 2019 | STSA | Satsuma Pharmaceuticals, ... | Shah Rajeev M. | Director | Buy | 15.00 | 192,387 | 2,885,805 | 4,681,858 |
| Sep 17 2019 | STSA | Satsuma Pharmaceuticals, ... | Shah Rajeev M. | Director | Option Exercise | 0.00 | 1,642,879 | 0 | 0 |
| Sep 17 2019 | STSA | Satsuma Pharmaceuticals, ... | Shah Rajeev M. | Director | Option Exercise | 0.00 | 365,530 | 0 | 0 |
| Sep 17 2019 | STSA | Satsuma Pharmaceuticals, ... | Shah Rajeev M. | Director | Option Exercise | 0.00 | 1,139,635 | 0 | 0 |
| Sep 17 2019 | STSA | Satsuma Pharmaceuticals, ... | Shah Rajeev M. | Director | Option Exercise | 0.00 | 200,481 | 0 | 0 |
| Jul 29 2019 | SLDB | Solid Biosciences Inc. | Shah Rajeev M. | Director | Buy | 4.65 | 1,881,720 | 8,749,998 | 4,571,164 |
| Jun 14 2019 | SLDB | Solid Biosciences Inc. | Shah Rajeev M. | Director | Option Exercise | 5.26 | 10,000 | 52,600 | 10,000 |
| Jun 13 2019 | RARX | Ra Pharmaceuticals, Inc. | Shah Rajeev M. | Director | Option Exercise | 19.88 | 15,000 | 298,200 | 15,000 |
| Jun 13 2019 | EIDX | Eidos Therapeutics, Inc. | Shah Rajeev M. | Director | Option Exercise | 30.87 | 21,528 | 664,569 | 21,528 |
| Jun 13 2019 | EIDX | Eidos Therapeutics, Inc. | Shah Rajeev M. | Director | Option Exercise | 30.87 | 21,528 | 664,569 | 21,528 |
| Jun 07 2019 | KALA | Kala Pharmaceuticals, Inc ... | Shah Rajeev M. | Director | Option Exercise | 5.35 | 21,000 | 112,350 | 21,000 |
| Dec 17 2018 | SLDB | Solid Biosciences Inc. | Shah Rajeev M. | Director | Option Exercise | 23.58 | 8,165 | 192,531 | 8,165 |
| Dec 14 2018 | RARX | Ra Pharmaceuticals, Inc. | Shah Rajeev M. | Director | Buy | 15.50 | 1,006,452 | 15,600,006 | 4,858,260 |
| Oct 05 2018 | KALA | Kala Pharmaceuticals, Inc ... | Shah Rajeev M. | Director | Buy | 8.25 | 2,424,242 | 19,999,997 | 4,537,478 |
| Oct 05 2018 | KALA | Kala Pharmaceuticals, Inc ... | Shah Rajeev M. | Director | Buy | 8.25 | 2,424,242 | 19,999,997 | 4,537,478 |
| Jul 26 2018 | SLDB | Solid Biosciences Inc. | Shah Rajeev M. | Director | Option Exercise | 37.89 | 1,835 | 69,528 | 1,835 |
| Jul 03 2018 | EIDX | Eidos Therapeutics, Inc. | Shah Rajeev M. | Director | Option Exercise | 20.34 | 43,056 | 875,759 | 43,056 |
| Jul 02 2018 | RARX | Ra Pharmaceuticals, Inc. | Shah Rajeev M. | Director | Option Exercise | 9.90 | 15,000 | 148,500 | 15,000 |
| Jun 22 2018 | EIDX | Eidos Therapeutics, Inc. | Shah Rajeev M. | Director | Buy | 0.00 | 1,103,847 | 0 | 1,103,847 |
| Jun 22 2018 | EIDX | Eidos Therapeutics, Inc. | Shah Rajeev M. | Director | Buy | 17.00 | 1,058,824 | 18,000,008 | 2,162,671 |
| Jun 22 2018 | EIDX | Eidos Therapeutics, Inc. | Shah Rajeev M. | Director | Option Exercise | 0.00 | 922,950 | 0 | 0 |
| Jun 15 2018 | KALA | Kala Pharmaceuticals, Inc ... | Shah Rajeev M. | Director | Option Exercise | 13.73 | 12,960 | 177,941 | 12,960 |
| Feb 16 2018 | RARX | Ra Pharmaceuticals, Inc. | Shah Rajeev M. | Director | Buy | 6.00 | 2,500,000 | 15,000,000 | 3,851,808 |
| Jan 30 2018 | SLDB | Solid Biosciences Inc. | Shah Rajeev M. | Director | Buy | 16.00 | 1,000,000 | 16,000,000 | 2,689,444 |
| Oct 16 2017 | KALV | KalVista Pharmaceuticals, ... | Shah Rajeev M. | Director | Buy | 8.50 | 850,000 | 7,225,000 | 1,441,070 |
| Sep 29 2017 | KALV | KalVista Pharmaceuticals, ... | Shah Rajeev M. | Director | Option Exercise | 6.71 | 6,000 | 40,260 | 6,000 |
| Jul 26 2017 | KALA | Kala Pharmaceuticals, Inc ... | Shah Rajeev M. | Director | Buy | 0.00 | 1,579,903 | 0 | 1,579,903 |
| Jul 26 2017 | KALA | Kala Pharmaceuticals, Inc ... | Shah Rajeev M. | Director | Buy | 15.00 | 533,333 | 7,999,995 | 2,113,236 |
| Jul 26 2017 | KALA | Kala Pharmaceuticals, Inc ... | Shah Rajeev M. | Director | Option Exercise | 0.00 | 3,819,444 | 0 | 0 |
| Jul 26 2017 | KALA | Kala Pharmaceuticals, Inc ... | Shah Rajeev M. | Director | Option Exercise | 0.00 | 4,409,170 | 0 | 0 |
| Jul 21 2017 | KALA | Kala Pharmaceuticals, Inc ... | Shah Rajeev M. | Director | Option Exercise | 15.00 | 12,960 | 194,400 | 12,960 |
| Jun 22 2017 | RARX | Ra Pharmaceuticals, Inc. | Shah Rajeev M. | Director | Option Exercise | 22.37 | 15,000 | 335,550 | 15,000 |
| Mar 27 2017 | CBYL | KalVista Pharmaceuticals, ... | Shah Rajeev M. | Director | Option Exercise | 7.88 | 12,000 | 94,560 | 12,000 |
| Nov 23 2016 | CBYL | KalVista Pharmaceuticals, ... | Shah Rajeev M. | Director | Buy | 0.00 | 591,070 | 0 | 591,070 |
| Oct 31 2016 | RARX | Ra Pharmaceuticals, Inc. | Shah Rajeev M. | Director | Buy | 0.00 | 616,646 | 0 | 616,646 |
| Oct 31 2016 | RARX | Ra Pharmaceuticals, Inc. | Shah Rajeev M. | Director | Buy | 0.00 | 573,624 | 0 | 1,190,270 |
| Oct 31 2016 | RARX | Ra Pharmaceuticals, Inc. | Shah Rajeev M. | Director | Buy | 13.00 | 161,538 | 2,099,994 | 1,351,808 |
| Oct 31 2016 | RARX | Ra Pharmaceuticals, Inc. | Shah Rajeev M. | Director | Option Exercise | 0.00 | 4,316,531 | 0 | 0 |
| Oct 31 2016 | RARX | Ra Pharmaceuticals, Inc. | Shah Rajeev M. | Director | Option Exercise | 0.00 | 4,015,378 | 0 | 0 |